½ÃÀ庸°í¼­
»óǰÄÚµå
1589719

¼¼°èÀÇ Àü±â¿µµ¿ ½ÃÀå : Àü±â¿µµ¿½Ã¾à, Àü±â¿µµ¿½Ã½ºÅÛ, °Ö À¯Çü, ÃÖÁ¾»ç¿ëÀÚº° ¿¹Ãø(2025-2030³â)

Electrophoresis Market by Electrophoresis Reagent, Electrophoresis System, Gel Type, End-User - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 198 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Àü±â¿µµ¿½ÃÀåÀº 2023³â 32¾ï 8,000¸¸ ´Þ·¯, 2024³â 34¾ï 7,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹»óµÇ¸ç, CAGR 6.11%·Î ¼ºÀåÇØ 2030³â 49¾ï 8,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

Àü±â¿µµ¿Àº DNA, RNA, ´Ü¹éÁú µîÀÇ ÇÏÀü ºÐÀÚ¸¦ Àü°è ÇÏ¿¡¼­ ±× Å©±â¿Í ÀüÇÏ¿¡ ±Ù°ÅÇÏ¿© ºÐ¸®Çϴµ¥ »ç¿ëµÇ´Â Çʼö ºÐ¼® ±â¼úÀÔ´Ï´Ù. ±× Çʿ伺Àº »ýÈ­ÇÐ, ºÐÀÚ »ý¹°ÇÐ, À¯ÀüÇÐ, ¹ýÀÇÇÐ µî ´Ù¾çÇÑ ºÎ¹®¿¡ °ÉÃÄ Áø´Ü, ¿¬±¸, â¾à¿¡ ÇʼöÀûÀÎ Á¤È®ÇÑ ºÐÀÚ ºÐ¸®¸¦ ±âÀçÇϰí ÀÖ½À´Ï´Ù. Áß¿äÇÑ ¿ªÇÒÀ» ¼öÇàÇÕ´Ï´Ù. »ý¸í °úÇÐ ¿¬±¸ÀÇ ±Þ¼ÓÇÑ ÁøÀü°ú ¸ÂÃãÇü ÀÇ·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡´Â Àü±â ¿µµ¿ ½ÃÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ÁÖ¿ä ¼ºÀå ¿äÀÎÀÔ´Ï´Ù. ºÐÇØ´É°ú °í¼Ó ÀÌ¿Í °°Àº ÀÌÁ¡À» Á¦°øÇÏ´Â ±â¼úÀÇ Áøº¸°¡ ÀÌ·¯ÇÑ ÃËÁø¿äÀÎÀÌ µÇ°í ÀÖ½À´Ï´Ù. ½Ã½ºÅÛÀÇ Á¤È®¼º°ú È¿À²¼º Çâ»ó ¿ì¸®´Â Àü·«Àû ÆÄÆ®³Ê½Ê°ú Á¦Ç° Çõ½Å¿¡ ÁÖ·ÂÇÔÀ¸·Î½á À̵éÀ» Ȱ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. ±×·¯³ª ½ÃÀåÀº Àü±â ¿µµ¿ ±â¼úÀÇ º¹À⼺, ¼÷·ÃµÈ Àü¹®°¡ÀÇ Á¦ÇÑµÈ °¡¿ë¼º, ÷´Ü Àåºñ ³ôÀº ºñ¿ë°ú °°Àº µµÀü ÀÌ¿¡ Á÷¸éÇϰí ÀÖÀ¸¸ç, À̰ÍÀÌ Ã¤¿ë·üÀÇ ¹æÇذ¡ µÇ°í ÀÖ½À´Ï´Ù. ÀÌ Á¦¾àÀ» ±Øº¹Çϱâ À§Çؼ­´Â ±â¼ú Çõ½ÅÀÌ ÁÖ·Î, ÀÚµ¿È­µÈ »ç¿ëÇϱ⠽¬¿î ½Ã½ºÅÛ, Á¶ÀÛÀÇ À庮°ú ÄÚ½ºÆ®¸¦ ³·Ãß´Â ÈÞ´ë ±â±âÀÇ °³¹ß ¿¡ ÁÖ·ÂÇØ¾ß ÇÕ´Ï´Ù. ºÎ¹®¿¡´Â ½Äǰ ¾ÈÀü ¹× ȯ°æ ºÐ¼®°ú °°Àº ½Å±Ô ºÎ¹®¿¡¼­ Àü±â ¿µµ¿ ¿ëµµ¸¦ ޱ¸ÇÏ´Â °Íµµ Æ÷ÇԵǾî ÀÖ½À´Ï´Ù. ±³À° ¹× ÈÆ·Ã ÇÁ·Î±×·¥ ±¸Çϱâ Àü±â ¿µµ¿ ½ÃÀåÀº °æÀïÀÌ Ä¡¿­ÇÏ°í ºó¹øÇÑ Áøº¸¿Í Â÷º°È­ÀÇ Çʿ伺ÀÌ Æ¯Â¡ÀÔ´Ï´Ù. ºñÁî´Ï½º ¼ºÀåÀ» °¡¼ÓÇÏ´Â µ¥ ÇʼöÀûÀÔ´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ (2023³â) 32¾ï 8,000¸¸ ´Þ·¯
¿¹Ãø³â(2024³â) 34¾ï 7,000¸¸ ´Þ·¯
¿¹Ãø³â(2030³â) 49¾ï 8,000¸¸ ´Þ·¯
CAGR(%) 6.11%

½ÃÀå ¿ªÇÐ: ±Þ¼ÓÈ÷ ÁøÈ­ÇÏ´Â Àü±â¿µµ¿ ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

Àü±â¿µµ¿½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ º¯¸ð¸¦ ÀÌ·ç°í ÀÖ½À´Ï´Ù. ºñÁî´Ï½º ±âȸ¸¦ ¾òÀ» ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ °æ°¨ÇÒ ¼ö ÀÖÀ½°ú µ¿½Ã¿¡ ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¶Ç´Â ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ»º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ´Ü¹éÁúüÇÐ ¹× À¯Àüü ¿¬±¸¿Í Àü±â¿µµ¿ ±â¼ú¿¡ ´ëÇÑ ÀÚ±Ý Á¦°ø Áõ°¡
    • »êÇÐ °øµ¿ ¿¬±¸ Áõ°¡
    • NGS ÀÌ¿ë Áõ°¡¿Í DNA ½ÃÄö½ÌÀÇ ºñ¿ë ÀúÇÏ
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • º¸´Ù ¿ì¼öÇÑ È¿À²°ú °á°ú¸¦ Á¦°øÇÏ´Â ´ëü ±â¼úÀÇ Á¸Àç
  • ½ÃÀå ±âȸ
    • ½ÅÈï±¹ÀÇ ³ôÀº ¼ºÀå ±âȸ
    • ¸ÂÃãÇü ÀÇ·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡
  • ½ÃÀåÀÇ °úÁ¦
    • Àü±â¿µµ¿ ½Ã¾à°ú °ü·ÃµÈ ¾ÈÀü¼º¿¡ ´ëÇÑ ¿ì·Á

Porter's Five Forces : Àü±â ¿µµ¿ ½ÃÀåÀ» Ž»öÇÏ´Â Àü·« µµ±¸

Porter's Five Forces Framework´Â Àü±â ¿µµ¿ ½ÃÀå °æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ³ª¿­µÇ¾î ÀÖ½À´Ï´Ù. ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÇÇÇÒ ¼ö ÀÖÀ¸¸ç ´õ °­ÀÎÇÑ ½ÃÀå¿¡¼­ Æ÷Áö¼Å´×À» º¸Àå ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : Àü±â ¿µµ¿ ½ÃÀå¿¡¼­ ¿ÜºÎ·ÎºÎÅÍÀÇ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº Àü±â ¿µµ¿ ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ»ÇÕ´Ï´Ù. ¸¦ Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. Àû±ØÀûÀÎ ÀÇ»ç °áÁ¤À» ÇÒ Áغñ°¡µÇ¾î ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : Àü±â ¿µµ¿ ½ÃÀå °æÀï ±¸µµ ÆÄ¾Ç

Àü±â ¿µµ¿ ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ¹àÈ÷´Ù ÀÌ ºÐ¼®À» ÅëÇØ ½ÃÀåÀÇ ÁýÁß, ºÎ¹®È­ ¹× ÅëÇÕ µ¿ÇâÀ» ¹àÇô³»°í º¥´õ´Â °æÀïÀÌ Ä¡¿­ÇØÁü¿¡ µû¶ó ÀÚ»çÀÇ ÁöÀ§¸¦ ³ôÀÌ´Â Àü·«Àû ÀÇ»ç °áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ Áö½ÄÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º : Àü±â ¿µµ¿ ½ÃÀå¿¡¼­ °ø±Þ¾÷üÀÇ ¼º´É Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â Àü±â ¿µµ¿ ½ÃÀå¿¡¼­ º¥´õ¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ±âº» °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù. ³× °¡Áö »çºÐ¸éÀ» ÅëÇØ º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ºÐÇÒÇϰí Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê ¹× ¼Ö·ç¼ÇÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× Ãßõ : Àü±â¿µµ¿ ½ÃÀå¿¡¼­ ¼º°øÀ» À§ÇÑ ±æÀ» ±×¸®±â

Àü±â¿µµ¿ ½ÃÀåÀÇ Àü·«ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ÀÇ ÇÁ·¹Á𽺠°­È­¸¦ ¸ñÇ¥·Î ÇÏ´Â ±â¾÷¿¡ ÇʼöÀûÀÔ´Ï´Ù. ÀÌ Á¢±Ù¹ýÀ» ÅëÇØ °æÀï ±¸µµ¿¡¼­ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö Àִ üÁ¦¸¦ ¸¶·ÃÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ ´Ù·ç´Â ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõ: ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·ÂÀ» Æò°¡ÇÕ´Ï´Ù.

2. ½ÃÀå °³Ã´µµ: ½ÅÈï ½ÃÀåÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ±âÁ¸ ºÎ¹®¿¡¼­ÀÇ È®Àå °¡´É¼ºÀ» Æò°¡Çϸç, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» ¼³¸íÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù¾çÈ­: ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, »ê¾÷ÀÇ ÁÖ¿ä Áøº¸, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú Áøº¸ µîÀ» °ËÁõÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÃÖ÷´Ü ±â¼ú, R&D Ȱµ¿, Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¸¦ ¾òÀº ÈÄ ÀÇ»ç°áÁ¤ÇÒ ¼ö ÀÖµµ·Ï Áß¿äÇÑ Áú¹®¿¡µµ ´ë´äÇϰí ÀÖ½À´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå ¿¹ÃøÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, Áö¿ªÀº ¾îµðÀԴϱî?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ¡¤Ã¶¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • ÇÁ·ÎÅ׿Ȱú À¯Àüü Á¶»ç¿Í Àü±â¿µµ¿ ±â¼ú¿¡ ´ëÇÑ ÀÚ±Ý Á¦°ø Áõ°¡
      • »êÇÐ ¿¬°è Á¶»ç Áõ°¡
      • NGSÀÇ ÀÌ¿ë Áõ°¡¿Í DNA ½ÃÄö½ÌÀÇ ºñ¿ë ÀúÇÏ
    • ¾ïÁ¦¿äÀÎ
      • º¸´Ù ¿ì¼öÇÑ È¿À²°ú °á°ú¸¦ °¡Á®¿À´Â ´ëü ±â¼úÀÇ Á¸Àç
    • ±âȸ
      • ½ÅÈï±¹ÀÇ ³ôÀº ¼ºÀå ±âȸ
      • ¸ÂÃãÇü ÀÇ·á ¼ö¿ä Áõ°¡
    • °úÁ¦
      • Àü±â¿µµ¿ ½Ã¾à°ú °ü·ÃµÈ ¾ÈÀü¼º ¿ì·Á
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ¹ý·ü
    • ȯ°æ

Á¦6Àå Àü±â¿µµ¿½ÃÀå : Àü±â¿µµ¿½Ã¾àº°

  • ¼Ò°³
  • ÇÙ»ê Àü±â¿µµ¿ ½Ã¾à
  • ´Ü¹éÁú Àü±â¿µµ¿ ½Ã¾à

Á¦7Àå Àü±â¿µµ¿ ½ÃÀå : Àü±â¿µµ¿ ½Ã½ºÅÛº°

  • ¼Ò°³
  • ¸ð¼¼°ü Àü±â¿µµ¿ ½Ã½ºÅÛ
  • °Öµ¶ ½Ã½ºÅÛ
  • ¼öÆò °Ö Àü±â¿µµ¿ ½Ã½ºÅÛ
  • ¼öÁ÷ °Ö Àü±â¿µµ¿ ½Ã½ºÅÛ
    • 1D °Ö Àü±â¿µµ¿
    • 2D °Ö Àü±â¿µµ¿

Á¦8Àå Àü±â¿µµ¿ ½ÃÀå : °Ö À¯Çüº°

  • ¼Ò°³
  • ¾Æ°¡·Î½º °Ö
  • Æú¸®¾ÆÅ©¸±¾Æ¹Ìµå °Ö

Á¦9Àå Àü±â¿µµ¿ ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

  • ¼Ò°³
  • Áø´Ü ½ÇÇè½Ç
  • ǰÁú °ü¸® ½ÇÇè½Ç
  • ¿¬±¸¼Ò

Á¦10Àå ¾Æ¸Þ¸®Ä«ÀÇ Àü±â¿µµ¿½ÃÀå

  • ¼Ò°³
  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦11Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ Àü±â¿µµ¿½ÃÀå

  • ¼Ò°³
  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦12Àå À¯·´¡¤Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ Àü±â¿µµ¿ ½ÃÀå

  • ¼Ò°³
  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦13Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®, 2023³â
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023³â
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
    • ¿ÀÇÏÀÌ¿À ÁÖ¸³ ´ëÇаú ¿ÀÅÍ ¹ÙÀÎ ´ëÇÐÀÇ ¿¬±¸ÀÚ°¡ Çù·ÂÇÏ¿© ¸ðµç Çгâ Çлý¿¡°Ô DNA Á¾ÀÌ Á¢±â¸¦ Àü´ÞÇÑ´Ù
    • CMP Scientific, ¸ð¼¼°ü Àü±â¿µµ¿ Áú·® ºÐ¼® ¼Ö·ç¼ÇÀÇ Áøº¸¸¦ À§ÇØ Agilent¿Í °øµ¿ ¸¶ÄÉÆÃ °è¾àÀ» ü°á
    • ij³ª´ÙÀÇ Advanced Electrophoresis Solutions Ltd´Â ¹ÙÀÌ¿À ÀǾàǰ »ê¾÷¿¡¼­ÀÇ »ç¾÷ È®´ë¸¦ À§ÇØ GCI ÁÖµµÀÇ ÅõÀÚ¸¦ ȹµæ
    • QIAGENÀº °í°¨µµ ¸ð¼¼°ü Àü±â¿µµ¿±â±â QIAxcel ConnectÀÇ ¹ß¸Å¿¡ ÀÇÇØ ÀÚµ¿È­ ¼Ö·ç¼ÇÀÇ ¹üÀ§¸¦ Áö¼ÓÀûÀ¸·Î °»½Å
    • Promega, ¸ðµç ¸ð¼¼°ü Àü±â ¿µµ¿ Ç÷§Æû°ú ȣȯµÇ´Â Sanger Sequencing Chemistry¸¦ Ãâ½Ã
    • Thermo Fisher Scientific, ÷´Ü ´Ü¹éÁú ºÐ¼®À» ÅëÇØ Ä¡·á °³¹ßÀ» °¡¼ÓÈ­Çϱâ À§ÇØ Advanced Electrophoresis Solutions Ltd¿ÍÀÇ °è¾àÀ» ¹ßÇ¥
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸ñ·Ï

  • Abdos Labtech Private Limited
  • Advanced Electrophoresis Solutions Ltd.
  • Agilent Technologies, Inc.
  • Analytik Jena GmbH Co. KG
  • Avantor by VWR International, LLC
  • Bento Bioworks Ltd.
  • Bex Co., Ltd.
  • Bio-Rad Laboratories, Inc.
  • Biobase Group
  • Biometer
  • CBS Scientific
  • Cleaver Scientific Ltd
  • Cole-Parmer Instrument Company, LLC.
  • Danaher Corporation
  • EPS Biosolutions
  • Helena Laboratories(UK) Limited
  • Hoefer, Inc
  • Kaneka Eurogentec SA
  • Lonza Group Ltd.
  • Medox BIoTech India Pvt. Ltd.
  • Merck KGaA
  • PerkinElmer, Inc
  • Photon Systems, Inc
  • QIAGEN GmbH
  • SERVA Electrophoresis GmbH
  • Takara Bio Inc
  • TBG Diagnostics Limited
  • Thermo Fisher Scientific Inc
JHS 24.11.21

The Electrophoresis Market was valued at USD 3.28 billion in 2023, expected to reach USD 3.47 billion in 2024, and is projected to grow at a CAGR of 6.11%, to USD 4.98 billion by 2030.

Electrophoresis is an essential analytical technique used to separate charged molecules, such as DNA, RNA, or proteins, based on their size and charge under an electric field. Its necessity spans across various disciplines, including biochemistry, molecular biology, genetics, and forensic science, providing precise molecular separation essential for diagnostics, research, and drug discovery. The scope of electrophoresis is broad, with applications in academic research, pharmaceuticals, clinical diagnostics, and biotechnology sectors, where it plays a pivotal role in genomics and proteomics. The rapid advancement in life sciences research and the growing demand for personalized medicine are key growth factors influencing the electrophoresis market. These drivers are propelled by technological advancements, such as capillary electrophoresis and microchip electrophoresis, which offer benefits of high resolution and speed. Opportunities for market expansion lie in emerging markets with increasing investments in healthcare infrastructure and the rising adoption of genomic technologies. Companies can capitalize on these by focusing on strategic partnerships and product innovation to enhance accuracy and efficiency of electrophoresis systems. However, the market faces challenges from the complexity of electrophoretic techniques, limited availability of skilled professionals, and the high cost of advanced equipment, which can hinder adoption rates. Innovation is key to overcoming these limitations, and efforts should focus on developing automated, user-friendly systems, and portable devices that lower operational barriers and costs. Areas of innovation could also include exploring electrophoresis applications in novel fields, such as food safety and environmental analysis. Additionally, the market demands continuous education and training programs to upskill professionals, ensuring effective use of evolving technologies. The electrophoresis market is highly competitive, characterized by frequent advancements and a need for differentiation. Therefore, strategic R&D investment and robust marketing strategies are essential to gaining competitive advantage and fostering sustained business growth.

KEY MARKET STATISTICS
Base Year [2023] USD 3.28 billion
Estimated Year [2024] USD 3.47 billion
Forecast Year [2030] USD 4.98 billion
CAGR (%) 6.11%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Electrophoresis Market

The Electrophoresis Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increase in funding for proteomic & genomic research and electrophoresis techniques
    • A growing number of industry-academia research collaborations
    • The increasing use of NGS and declining cost of DNA sequencing
  • Market Restraints
    • Presence of alternative technologies offering better efficiency & results
  • Market Opportunities
    • High growth opportunities in emerging countries
    • Increasing demand for personalized medicine
  • Market Challenges
    • Safety concerns associated with electrophoresis reagents

Porter's Five Forces: A Strategic Tool for Navigating the Electrophoresis Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Electrophoresis Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Electrophoresis Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Electrophoresis Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Electrophoresis Market

A detailed market share analysis in the Electrophoresis Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Electrophoresis Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Electrophoresis Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Electrophoresis Market

A strategic analysis of the Electrophoresis Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Electrophoresis Market, highlighting leading vendors and their innovative profiles. These include Abdos Labtech Private Limited, Advanced Electrophoresis Solutions Ltd., Agilent Technologies, Inc., Analytik Jena GmbH+Co. KG, Avantor by VWR International, LLC, Bento Bioworks Ltd., Bex Co., Ltd., Bio-Rad Laboratories, Inc., Biobase Group, Biometer, CBS Scientific, Cleaver Scientific Ltd, Cole-Parmer Instrument Company, LLC., Danaher Corporation, EPS Biosolutions, Helena Laboratories (UK) Limited, Hoefer, Inc, Kaneka Eurogentec S.A., Lonza Group Ltd., Medox Biotech India Pvt. Ltd., Merck KGaA, PerkinElmer, Inc, Photon Systems, Inc, QIAGEN GmbH, SERVA Electrophoresis GmbH, Takara Bio Inc, TBG Diagnostics Limited, and Thermo Fisher Scientific Inc.

Market Segmentation & Coverage

This research report categorizes the Electrophoresis Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Electrophoresis Reagent, market is studied across Nucleic Acid Electrophoresis Reagents and Protein Electrophoresis Reagents.
  • Based on Electrophoresis System, market is studied across Capillary Electrophoresis Systems, Gel Doc Systems, Horizontal Gel Electrophoresis Systems, and Vertical Gel Electrophoresis Systems. The Vertical Gel Electrophoresis Systems is further studied across 1D Gel Electrophoresis and 2D Gel Electrophoresis.
  • Based on Gel Type, market is studied across Agarose Gel and Polyacrylamide Gel.
  • Based on End-User, market is studied across Diagnostic Labs, Quality Control Labs, and Research Laboratories.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increase in funding for proteomic & genomic research and electrophoresis techniques
      • 5.1.1.2. A growing number of industry-academia research collaborations
      • 5.1.1.3. The increasing use of NGS and declining cost of DNA sequencing
    • 5.1.2. Restraints
      • 5.1.2.1. Presence of alternative technologies offering better efficiency & results
    • 5.1.3. Opportunities
      • 5.1.3.1. High growth opportunities in emerging countries
      • 5.1.3.2. Increasing demand for personalized medicine
    • 5.1.4. Challenges
      • 5.1.4.1. Safety concerns associated with electrophoresis reagents
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Electrophoresis Market, by Electrophoresis Reagent

  • 6.1. Introduction
  • 6.2. Nucleic Acid Electrophoresis Reagents
  • 6.3. Protein Electrophoresis Reagents

7. Electrophoresis Market, by Electrophoresis System

  • 7.1. Introduction
  • 7.2. Capillary Electrophoresis Systems
  • 7.3. Gel Doc Systems
  • 7.4. Horizontal Gel Electrophoresis Systems
  • 7.5. Vertical Gel Electrophoresis Systems
    • 7.5.1. 1D Gel Electrophoresis
    • 7.5.2. 2D Gel Electrophoresis

8. Electrophoresis Market, by Gel Type

  • 8.1. Introduction
  • 8.2. Agarose Gel
  • 8.3. Polyacrylamide Gel

9. Electrophoresis Market, by End-User

  • 9.1. Introduction
  • 9.2. Diagnostic Labs
  • 9.3. Quality Control Labs
  • 9.4. Research Laboratories

10. Americas Electrophoresis Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Electrophoresis Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Electrophoresis Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Ohio State and Otterbein researchers collaborate to bring DNA origami to students of all grade levels
    • 13.3.2. CMP scientific signs a co-marketing agreement with agilent to advance capillary electrophoresis-mass spectrometry solutions
    • 13.3.3. Canadian high-tech advanced electrophoresis solutions ltd. secured gci-led investment to expand its business in biopharma industry
    • 13.3.4. QIAGEN continues to update its range of automation solutions with the launch of high-sensitive capillary electrophoresis instrument QIAxcel Connect
    • 13.3.5. Promega launches sanger sequencing chemistry compatible with all capillary electrophoresis platforms
    • 13.3.6. Thermo fisher scientific announces agreement with advanced electrophoresis solutions ltd to accelerate therapeutic development through cutting-edge protein analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abdos Labtech Private Limited
  • 2. Advanced Electrophoresis Solutions Ltd.
  • 3. Agilent Technologies, Inc.
  • 4. Analytik Jena GmbH+Co. KG
  • 5. Avantor by VWR International, LLC
  • 6. Bento Bioworks Ltd.
  • 7. Bex Co., Ltd.
  • 8. Bio-Rad Laboratories, Inc.
  • 9. Biobase Group
  • 10. Biometer
  • 11. CBS Scientific
  • 12. Cleaver Scientific Ltd
  • 13. Cole-Parmer Instrument Company, LLC.
  • 14. Danaher Corporation
  • 15. EPS Biosolutions
  • 16. Helena Laboratories (UK) Limited
  • 17. Hoefer, Inc
  • 18. Kaneka Eurogentec S.A.
  • 19. Lonza Group Ltd.
  • 20. Medox Biotech India Pvt. Ltd.
  • 21. Merck KGaA
  • 22. PerkinElmer, Inc
  • 23. Photon Systems, Inc
  • 24. QIAGEN GmbH
  • 25. SERVA Electrophoresis GmbH
  • 26. Takara Bio Inc
  • 27. TBG Diagnostics Limited
  • 28. Thermo Fisher Scientific Inc
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦